Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study

Abstract Introduction Subjects with intellectual disability are usually excluded from clinical trials and there is limited evidence-based guidance for the choice of antiseizure medications in this vulnerable population. The study explored the effectiveness of brivaracetam (BRV) in people with epilep...

Full description

Saved in:

Bibliographic Details
Main Authors:	Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, Sara Casciato, Emanuele Cerulli Irelli, Valentina Chiesa, Filippo Dainese, Giovanni De Maria, Giuseppe Didato, Giancarlo Di Gennaro, Giovanni Falcicchio, Martina Fanella, Edoardo Ferlazzo, Massimo Gangitano, Angela La Neve, Oriano Mecarelli, Elisa Montalenti, Alessandra Morano, Federico Piazza, Chiara Pizzanelli, Patrizia Pulitano, Federica Ranzato, Eleonora Rosati, Laura Tassi, Carlo Di Bonaventura, on behalf of BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) Group Membership
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2025-03-01
Series:	Neurology and Therapy
Subjects:	Antiseizure medication Brivaracetam Focal seizures Epilepsy Intellectual disability
Online Access:	https://doi.org/10.1007/s40120-025-00717-x
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study

Similar Items